I recently checked the stocks I own to see how they're performing so far in 2018. Year-to-date gains of more than 20% for three of my stocks brought a smile to my face. That's not bad at all for less than halfway through the year, but it pales in comparison to the performance of three drug stocks in just the last five days.
3 Drug Stocks That Soared This Week: Are They Buys?
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться